ETF

Global X Genomics & Biotech ETF USD Acc

ISIN
IE00BM8R0N95

How good is this fund, really?

See the rating in the app

About Global X Genomics & Biotech ETF USD Acc

Genomic science and biotechnology are the focus. Global X Genomics & Biotech ETF USD Acc replicates the Solactive Genomics v2 Index, which covers listed companies in gene editing, genomic sequencing, genetic medicines and therapies, and computational genomics and diagnostics. The index admits three kinds of company: pure-play firms with at least 50% of revenue from genomics, pre-revenue firms whose main business is genomics, and diversified firms earning some, but less than 50%, of revenue there. The ETF is a passively managed sub-fund of Global X ETFs ICAV, managed by Global X Management Company (Europe) Limited. Income is accumulated. A 0.50% ongoing charge applies, and the fund sits in risk category 7 of 7. This class launched on 2 November 2021.

Watch this fund for free Add Global X Genomics & Biotech ETF USD Acc to your watchlist in the PowerFunds app and we tell you when it falls behind the rest of its category.

Watch the fund for free

Where to buy Global X Genomics & Biotech ETF USD Acc — platforms and fees

Sold on 3 platforms we follow.

Global X Genomics & Biotech ETF USD Acc — its category

Sector Equity Biotechnology — PowerFunds rates 55 funds in this category every month.

Biotechnology funds →

Other funds